Polymerase Chain Reaction Market Analysis | CMI

1

• Coherent Market Insights
• Market Research and Business Consulting Services
• https//www.coherentmarketinsights.com/
• COVID-19 Impact Tracker

2
POLYMERASE CHAIN REACTION MARKET ANALYSIS

• Polymerase Chain Reaction Market, by Product Type
  (Instrument (Real Time PCR, Digital PCR, Others)
  Reagents and Consumables)), by End User (Clinical
  Diagnostics, Academic and Research Laboratories,
  Forensic Laboratories, Others) - Global Industry
  Insights, and Forecast to 2025
• The global polymerase chain reaction market was
  valued at US 3.7 billion in 2017 and is expected
  to witness a CAGR of 8.8 over the forecast
  period (2017 2025).

3
Global Polymerase Chain Reaction Market Share
(), By Product Type
4
Market Drivers

• Increasing Numbers of Product Launches and
  Collaborations in Polymerase Chain Reaction are
  expected to Drive Growth of the Polymerase Chain
  Reaction Market
• Key players in the polymerase chain reaction
  market are engaged in launching advanced and
  novel PCR instruments and consumables, which will
  allows rapid and easy nucleic acid amplification.
  For instance, in October 2017, Diatech
  Pharmacogenetics srl launched easyPGX a ready to
  use in-vitro diagnostic real-time PCR product
  line and Helix a polymerase chain reaction kit
  for the extraction of circulating free DNA from
  plasma. In September 2015, Bio-Rad Laboratories
  launched droplet digital PCR (ddPCR) Supermix for
  Residual DNA Quantification. The new supermix
  designed to use with Bio-Rads Droplet Digital
  PCR Systems offers highly precise and sensitive
  method for DNA measurement. In November 2014,
  Chai Biotechnologies Inc. introduced Open qPCR
  Real-Time PCR Thermocycler. The new instrument is
  designed to use for genetic genotyping, pathogen
  detection, and relative DNA quantification.
  Moreover, in April 2014, Bio-Rad Laboratories
  launched Precision Blue Real-Time PCR Dye. The
  new Precision Blue dye is compatible with
  Bio-Rads universal qPCR supermixes, and can be
  used with all Bio-Rads CFx real time PCR
  systems.
• Furthermore, key players are involved in several
  collaborations to expand their geographical
  horizon and increase patient reach. For instance,
  in March 2018, Akonni Biosystems Inc. and a
  Chinese in-vitro diagnostics company Righton
  signed a commercial agreement, which enables
  Righton to sell Akonni's TruDiagnosis and TruTip
  Nucleic Acid Purification Kits in China.
  TruDiagnosis is based on proprietary on-slide PCR
  and gel-drop microarray technology. In January
  2018, Thermo Fisher Scientific and Illumina, Inc.
  signed a commercial agreement. Under the
  agreement, Thermo Fisher will provide Ion
  AmpliSeq technology to Illumina for research
  purpose. Moreover, in December 2017, Genome
  Diagnostics (GenDx) signed a global reseller
  agreement with Thermo Fisher Scientific,
  assigning GenDx as a non-exclusive reseller of
  Thermo Fishers QuantStudio real-time PCR
  instrument. Under the agreement, GenDx will
  market the QuantStudio real-time PCR in the
  Netherlands and other European countries. Thus,
  significant organic and inorganic growth
  strategies by various key players is driving
  growth of the polymerase chain reaction market.

5

• Increasing Prevalence of Chronic and Infectious
  Disease are Driving Growth of Polymerase Chain
  Reaction Market
• Polymerase chain reaction is increasingly used in
  clinical diagnosis of infectious disease, nucleic
  acid amplification, paternity testing, DNA
  fingerprinting, detection and diagnosis of
  infectious disease, quality control, and
  personalized medicine. For instance, according to
  the Centers for Disease Control and Prevention
  (CDC), around 5,251 deaths due to the influenza
  infection were registered in 2015, in U.S.
  According to the World Health Organization (WHO),
  in 2015, around 32,000 estimated deaths were
  reported from tuberculosis and around 3, 23,000
  new cases of TB cases were registered in the
  European region. According to the National
  Ambulatory Medical Care Survey 2015 data
  findings, 16.8 million visits to physician
  offices for infectious and parasitic diseases
  were registered in the U.S. According to the
  World Health Organization (WHO), 2016, around
  555,318 new cases of cancer were reported in
  2012, in the Middle East Region. The region is
  expected to witness the highest relative increase
  of cancer cases among the regions in the world
  accounting to 961,098 cases by 2030. Moreover,
  according to the Cancer Atlas, 2012, about 1.1
  million new cancer cases and 600,000 cancer
  deaths occurred annually in Latin America and the
  Caribbean, where lung cancer is the leading cause
  of cancer death for both genders combined in the
  region.

6
Market Restraints

• However, advances in research are leading to
  generation of various alternative nucleic acid
  amplification methods, which may hinder growth of
  the polymerase chain reaction market over the
  forecasted period. Such alternative methods of
  nucleic acid amplification includes loop
  medicated isothermal amplification, nucleic acid
  sequence based amplification, strand displacement
  amplification, and multiple displacement
  amplification. These methods offers better
  applicability and sensitivity in nucleic acid
  amplification, where PCR shows limitations such
  as contamination, sensitivity to certain classes
  of contaminants and inhibitors, and requirement
  of thermal cycling.
• Key players in the polymerase chain reaction are
  engaged in offering PCR-free nucleic acid
  detection methods. For instance, in March 2018,
  Quanterix Corporation and DestiNA Genomics
  collaborated to develop PCR-free microRNA
  detection method with high-specificity and
  ultra-sensitivity, thereby enhancing RNA
  biomarker detection.

7
Key Players

• Key players operating in polymerase chain
  reaction market include F. Hoffmann-La Roche Ltd,
  Bio-Rad Laboratories, Inc., Thermo Fisher
  Scientific Inc., Agilent Technologies, Inc.,
  bioMérieux, S.A., Enzo Life Science, Inc., Abbott
  Laboratories, Takara Bio Inc., Becton, Dickinson
  and Company, and Danaher Corporation.

8

• Request Sample Report
• Request Customization
• Download PDF Brochure
• Talk to Analyst
• Reference https//www.coherentmarketinsights.com
  /market-insight/polymerase-chain-reaction-market-1
  546

9
About Us

• Coherent Market Insights is a global market
  intelligence and consulting organization focused
  on assisting our plethora of clients achieve
  transformational growth by helping them make
  critical business decisions.
• What we provide
• Customized Market Research Services
• Industry Analysis Services
• Business Consulting Services
• Market Intelligence Services
• Long term Engagement Model
• Country Specific Analysis

10
Contact Us

• Mr. Shah
• Coherent Market Insights Pvt.Ltd.
• Address 1001 4th Ave, 3200 Seattle, WA 98154,
  U.S.
• Phone [phone]
• Email sales_at_coherentmarketinsights.com

11

• Thank You!
• Kindly follow CMI Social Media Profiles
  for the latest company updates
• Facebook
• Linkedin
• Twitter
• https//www.coherentmarketinsights.com/